1. Association of GERD with Sleeve Gastrectomy: An Unintended Consequence. Curr Diab Rep. 2026 Jan 29; 26(1):3. Talebloo J, Gadde KM, Mittal RK, Nguyen NT. PMID: 41606240; PMCID: PMC12852246.

    View in:

    PubMed   Mentions:

       Fields: 

       
  2. Sociodemographic, Clinical, and Psychosocial Predictors of Short- and Long-term Study Retention in the Diabetes Prevention Program (DPP) Outcomes Study (DPPOS). Diabetes Care. 2025 Oct 01; 48(10):1685-1694. Tjaden AH, Braffett BH, Butera NM, Araneta MR, Carmichael O, Groessl EJ, Hazuda HP, Hoskin MA, Ibebuogu U, Magee MF, Mau M, Stich T, Soliman D, Wallia A, Temprosa M, Golden SH, Diabetes Prevention Program Research Group . PMID: 40541257; PMCID: PMC12451849.

    View in:

    PubMed   Mentions:

       Fields: 

       Translation:

    Humans
  3. Analysis of Long-term Follow-up of a Randomized Clinical Trial With Departures From Assigned Treatments: Estimation of Metformin Effects on Diabetes and Its Complications in the Diabetes Prevention Program Outcomes Study. Diabetes Care. 2025 Oct 01; 48(10):1668-1675. Knowler WC, Pan Q, Shu S, Tripputi MT, Dabelea D, Edelstein SL, Kahn SE, Kuo S, Luchsinger JA, Shah V, Wallia A, Temprosa M, Diabetes Prevention Program Research Group . PMID: 40857175; PMCID: PMC12451852.

    View in:

    PubMed   Mentions:
  4. Impact of Parental or First-Degree Family History of Diabetes on Diabetes Incidence and Progression During Long-term Follow-up in the Diabetes Prevention Program Outcomes Study. Diabetes Care. 2025 Oct 01; 48(10):1695-1703. Dagogo-Jack S, Kazemi EJ, Doherty L, Srikanthan P, Echouffo-Tcheugui JB, Knowler WC, Kahn SE, Mudaliar S, Temprosa M, DPP Research Group . PMID: 40882001; PMCID: PMC12451838.

    View in:

    PubMed   Mentions:

       Fields: 

       Translation:

    Humans
  5. Nonglycemic and Glycemic Risk Factors for Painful Neuropathic Symptoms and for Distal Symmetrical Polyneuropathy (DSPN) in the Diabetes Prevention Program/Diabetes Prevention Program Outcomes Study. Diabetes Care. 2025 Oct 01; 48(10):1676-1684. Herman WH, Ciarleglio A, Callaghan BC, Edelstein SL, Goldberg R, White NH, Albers JW, Diabetes Prevention Program Research Group . PMID: 40532190; PMCID: PMC12451832.

    View in:

    PubMed   Mentions:
  6. Peripheral CB1 receptor blockade for treatment of obesity. Lancet Diabetes Endocrinol. 2025 Nov; 13(11):898-899. Gadde KM, Talebloo J, Piomelli D. PMID: 41038214.

    View in:

    PubMed   Mentions:

       Fields: 

       
  7. Association of BMI and Cognitive Performance in the Diabetes Prevention Program Outcomes Study. Obesity (Silver Spring). 2025 Dec; 33(12):2365-2376. Luchsinger JA, Pan Q, Knowler WC, Munshi M, Watson K, Gadde KM, Schlögl M, Carmichael OT, DPP Research Group. PMID: 41017217; PMCID: PMC12636062.

    View in:

    PubMed   Mentions:
  8. Key genetic determinants of diabetes remission in patients with obesity following bariatric surgery. Updates Surg. 2025 Dec; 77(8):2579-2590. Mahjoubin-Tehran M, Talebloo J, Gadde KM, Sukhorukov VN, Jamialahmadi T, Sahebkar A. PMID: 40993333.

    View in:

    PubMed   Mentions:

       Fields: 

       Translation:

    HumansCells
  9. The Diabetes Prevention Program and Its Outcomes Study: NIDDK's Journey Into the Prevention of Type 2 Diabetes and Its Public Health Impact. Diabetes Care. 2025 Jul 01; 48(7):1101-1111. Crandall JP, Dabelea D, Knowler WC, Nathan DM, Temprosa M, DPP Research Group . PMID: 40272279; PMCID: PMC12178622.

    View in:

    PubMed

       Mentions:

    7  

       Fields: 

       Translation:

    HumansPHPublic Health
  10. Long-term changes in lipid indices following Roux-en-Y gastric bypass: a meta-analysis. Surg Endosc. 2025 Jul; 39(7):4109-4127. Jamialahamdi T, Mirhadi E, Abdalla MA, Gadde KM, Almahmeed W, Eid AH, Ahmad S, Ahmad I, Kroh M, Sahebkar A. PMID: 40325244.

    View in:

    PubMed

       Mentions:

    1  

       Fields: 

       Translation:

    Humans
  11. Long-term effects and effect heterogeneity of lifestyle and metformin interventions on type 2 diabetes incidence over 21 years in the US Diabetes Prevention Program randomised clinical trial. Lancet Diabetes Endocrinol. 2025 Jun; 13(6):469-481. Knowler WC, Doherty L, Edelstein SL, Bennett PH, Dabelea D, Hoskin M, Kahn SE, Kalyani RR, Kim C, Pi-Sunyer FX, Raghavan S, Shah VO, Temprosa M, Venditti EM, Nathan DM, DPP/DPPOS Research Group. PMID: 40311647; PMCID: PMC12414453.

    View in:

    PubMed

       Mentions:

    10  

       Fields: 

       Translation:

    Humans
  12. Flap Valve-Preserving Vertical Sleeve Gastrectomy (INNOVATE-VSG): Clinical Trial Study Protocol. Obes Surg. 2025 Mar; 35(3):1063-1069. Nguyen NT, Gadde KM, Mittal RK. PMID: 39985715; PMCID: PMC11906530.

    View in:

    PubMed

       Mentions:

    3  

       Fields: 

       Translation:

    HumansCTClinical Trials
  13. Beyond fat: Does semaglutide affect lean mass? Clin Nutr. 2025 Jan; 44:104-108. Jamialahmadi T, Eid AH, Gadde KM, Almahmeed W, Kroh M, Al Zein M, Sahebkar A. PMID: 39647240.

    View in:

    PubMed   Mentions:

       Fields: 

       Translation:

    Humans
  14. New Generation Anti-Obesity Pharmacotherapy: Companion or Competitor to Metabolic bariatric Surgery? Drug Discov Today. 2024 Aug; 29(8):104072. Sahebkar A, Gadde KM, Kroh M, Eid AH, Jamialahmadi T. PMID: 38942072.

    View in:

    PubMed   Mentions:

       Fields: 

       Translation:

    HumansAnimals
  15. Impact of bariatric surgery on circulating irisin levels: a systematic review and meta‑analysis. Updates Surg. 2024 Dec; 76(8):2745-2754. Jamialahamdi T, Mirhadi E, Almahmeed W, Eid AH, Al-Rasadi K, Nguyen NT, Gadde KM, Sahebkar A. PMID: 38743243.

    View in:

    PubMed

       Mentions:

    1  

       Fields: 

       Translation:

    Humans
  16. Temporal dynamics of the multi-omic response to endurance exercise training. Nature. 2024 May; 629(8010):174-183. MoTrPAC Study Group, Lead Analysts, MoTrPAC Study Group. PMID: 38693412; PMCID: PMC11062907.

    View in:

    PubMed   Mentions:
  17. Prevalence of Distal Symmetrical Polyneuropathy by Diabetes Prevention Program Treatment Group, Diabetes Status, Duration of Diabetes, and Cumulative Glycemic Exposure. Diabetes Care. 2024 May 01; 47(5):810-817. Lee CG, Ciarleglio A, Edelstein SL, Crandall JP, Dabelea D, Goldberg RB, Kahn SE, Knowler WC, Ma MT, White NH, Herman WH, Diabetes Prevention Program Research Group . PMID: 38502874; PMCID: PMC11043227.

    View in:

    PubMed

       Mentions:

    5  

       Fields: 

       Translation:

    Humans
  18. Bariatric Surgery Improves Serum CD40L Levels as a Predictor of Cardiovascular Risk: Systematic Review and Meta-analysis. Obes Surg. 2024 May; 34(5):1929-1937. Jamialahamdi T, Eid AH, Nguyen NT, Gadde KM, Sukhorukov VN, Almahmeed W, Kroh M, Sahebkar A. PMID: 38578522.

    View in:

    PubMed   Mentions:

       Fields: 

       
  19. Prevalence and predictors of female sexual dysfunction among sexually active women in the diabetes prevention program outcomes study. Neurourol Urodyn. 2024 Apr; 43(4):977-990. Gupta P, Doherty L, Temprosa M, Pop-Busui R, Gadde KM, Singh P, Owora AH, Wessells H, Sarma AV, Diabetes Prevention Program Research Group. PMID: 38501372; PMCID: PMC12285218.

    View in:

    PubMed

       Mentions:

    1  

    Translation:

    Humans
  20. Prevalence and predictors of erectile dysfunction among men in the diabetes prevention program outcomes study. J Diabetes Complications. 2024 02; 38(2):108669. Blair YA, Doherty L, Temprosa M, Pop-Busui R, Gadde KM, Singh P, Owora AH, Wessells H, Sarma AV, Diabetes Prevention Program Research Group. PMID: 38219334; PMCID: PMC10922921.

    View in:

    PubMed   Mentions:

       Fields: 

       Translation:

    Humans
  21. Improvement of Triglyceride-Glucose Index Following Bariatric Surgery: a Systematic Review and Meta-analysis. Obes Surg. 2024 Mar; 34(3):741-750. Jamialahamdi T, Gadde KM, Nguyen NT, Kroh M, Sukhorukov VN, Almahmeed W, Al-Rasadi K, Sahebkar A. PMID: 38102370.

    View in:

    PubMed

       Mentions:

    1  

       Fields: 

       Translation:

    Humans
  22. Effects of testosterone enanthate on aggression, risk-taking, competition, mood, and other cognitive domains during 28 days of severe energy deprivation. Psychopharmacology (Berl). 2024 Mar; 241(3):461-478. Lieberman HR, Caldwell JA, Vartanian O, Carmichael OT, Karl JP, Berryman CE, Gadde KM, Niro PJ, Harris MN, Rood JC, Pasiakos SM. PMID: 38038817; PMCID: PMC10884082.

    View in:

    PubMed

       Mentions:

    1  

       Fields: 

       Translation:

    Humans
  23. Coronary Artery Calcium and Cognitive Decline in the Diabetes Prevention Program Outcomes Study. J Am Heart Assoc. 2023 11 07; 12(21):e029671. Gadde KM, Yin X, Goldberg RB, Orchard TJ, Schlögl M, Dabelea D, Ibebuogu UN, Watson KE, Pi-Sunyer FX, Crandall JP, Temprosa M, Luchsinger JA, Diabetes Prevention Program Research Group. PMID: 37929764; PMCID: PMC10727391.

    View in:

    PubMed

       Mentions:

    6  

       Fields: 

       Translation:

    Humans
  24. Analysis of Veno-Venous Extracorporeal Membrane Oxygenation for COVID-19 Compared to Non-COVID Etiologies. Ann Surg. 2023 09 01; 278(3):464-470. Ruhi-Williams P, Wu B, Nahmias J, Sagebin F, Fazl Alizadeh R, Gadde KM, Amin A, Nguyen NT. PMID: 37325899.

    View in:

    PubMed

       Mentions:

    2  

       Fields: 

       Translation:

    Humans
  25. Pharmacotherapy for obesity: recent evolution and implications for cardiovascular risk reduction. Expert Rev Endocrinol Metab. 2023 Sep-Nov; 18(4):307-319. Maki KC, Kirkpatrick CF, Allison DB, Gadde KM. PMID: 37199542.

    View in:

    PubMed

       Mentions:

    4  

       Fields: 

       Translation:

    Humans
  26. Weight Regain After Bariatric Surgery: Scope of the Problem, Causes, Prevention, and Treatment. Curr Diab Rep. 2023 03; 23(3):31-42. Noria SF, Shelby RD, Atkins KD, Nguyen NT, Gadde KM. PMID: 36752995; PMCID: PMC9906605.

    View in:

    PubMed

       Mentions:

    85  

       Fields: 

       Translation:

    Humans
  27. Erratum. Effects of Cotadutide on Metabolic and Hepatic Parameters in Adults With Overweight or Obesity and Type 2 Diabetes: A 54-Week Randomized Phase 2b Study. Diabetes Care 2021;44:1433-1442. Diabetes Care. 2022 Dec 01; 45(12):3112. Nahra R, Wang T, Gadde KM, Oscarsson J, Stumvoll M, Jermutus L, Hirshberg B, Ambery P. PMID: 36228195; PMCID: PMC9763024.

    View in:

    PubMed   Mentions:

       Fields: 

       
  28. Risk of Type 2 Diabetes Among Individuals with Excess Weight: Weight Trajectory Effects. Curr Diab Rep. 2022 09; 22(9):471-479. Owora AH, Allison DB, Zhang X, Gletsu-Miller N, Gadde KM. PMID: 35781782; PMCID: PMC10094425.

    View in:

    PubMed

       Mentions:

    3  

       Fields: 

       Translation:

    Humans
  29. Effects of Long-term Metformin and Lifestyle Interventions on Cardiovascular Events in the Diabetes Prevention Program and Its Outcome Study. Circulation. 2022 05 31; 145(22):1632-1641. Goldberg RB, Orchard TJ, Crandall JP, Boyko EJ, Budoff M, Dabelea D, Gadde KM, Knowler WC, Lee CG, Nathan DM, Watson K, Temprosa M, Diabetes Prevention Program Research Group*. PMID: 35603600; PMCID: PMC9179081.

    View in:

    PubMed

       Mentions:

    71  

       Fields: 

       Translation:

    Humans
  30. The Role of Calorie Restriction in the Prevention of Cardiovascular Disease. Curr Atheroscler Rep. 2022 04; 24(4):235-242. Perry CA, Gadde KM. PMID: 35107761.

    View in:

    PubMed

       Mentions:

    14  

       Fields: 

       Translation:

    Humans
  31. Obesity, Body Composition, and Sex Hormones: Implications for Cardiovascular Risk. Compr Physiol. 2021 12 29; 12(1):2949-2993. Singh P, Covassin N, Marlatt K, Gadde KM, Heymsfield SB. PMID: 34964120; PMCID: PMC10068688.

    View in:

    PubMed

       Mentions:

    19  

       Fields: 

       Translation:

    Humans
  32. Long-acting amylin analogue for weight reduction. Lancet. 2021 12 11; 398(10317):2132-2134. Gadde KM, Allison DB. PMID: 34798059.

    View in:

    PubMed

       Mentions:

    3  

       Fields: 

       Translation:

    Humans
  33. Effect of Metformin and Lifestyle Interventions on Mortality in the Diabetes Prevention Program and Diabetes Prevention Program Outcomes Study. Diabetes Care. 2021 12; 44(12):2775-2782. Lee CG, Heckman-Stoddard B, Dabelea D, Gadde KM, Ehrmann D, Ford L, Prorok P, Boyko EJ, Pi-Sunyer X, Wallia A, Knowler WC, Crandall JP, Temprosa M, Diabetes Prevention Program Research Group, Diabetes Prevention Program Research Group:. PMID: 34697033; PMCID: PMC8669534.

    View in:

    PubMed

       Mentions:

    38  

       Fields: 

       Translation:

    Humans
  34. Targeting visceral adiposity with pharmacotherapy. Lancet Diabetes Endocrinol. 2021 09; 9(9):551-552. Gadde KM, Heymsfield SB. PMID: 34358470.

    View in:

    PubMed

       Mentions:

    3  

       Fields: 

       Translation:

    Humans
  35. Effects of Cotadutide on Metabolic and Hepatic Parameters in Adults With Overweight or Obesity and Type 2 Diabetes: A 54-Week Randomized Phase 2b Study. Diabetes Care. 2021 06; 44(6):1433-1442. Nahra R, Wang T, Gadde KM, Oscarsson J, Stumvoll M, Jermutus L, Hirshberg B, Ambery P. PMID: 34016612; PMCID: PMC8247525.

    View in:

    PubMed

       Mentions:

    121  

       Fields: 

       Translation:

    Humans
  36. Testosterone supplementation upregulates androgen receptor expression and translational capacity during severe energy deficit. Am J Physiol Endocrinol Metab. 2020 10 01; 319(4):E678-E688. Howard EE, Margolis LM, Berryman CE, Lieberman HR, Karl JP, Young AJ, Montano MA, Evans WJ, Rodriguez NR, Johannsen NM, Gadde KM, Harris MN, Rood JC, Pasiakos SM. PMID: 32776828; PMCID: PMC7750513.

    View in:

    PubMed

       Mentions:

    13  

       Fields: 

       Translation:

    HumansCells
  37. The limits and challenges of antiobesity pharmacotherapy. Expert Opin Pharmacother. 2020 Aug; 21(11):1319-1328. Gadde KM, Atkins KD. PMID: 32292094; PMCID: PMC7523877.

    View in:

    PubMed

       Mentions:

    21  

       Fields: 

       Translation:

    Humans
  38. Effects of Testosterone Supplementation on Ghrelin and Appetite During and After Severe Energy Deficit in Healthy Men. J Endocr Soc. 2020 Apr 01; 4(4):bvaa024. Karl JP, Berryman CE, Harris MN, Lieberman HR, Gadde KM, Rood JC, Pasiakos SM. PMID: 32258956; PMCID: PMC7101089.

    View in:

    PubMed

       Mentions:

    6  
  39. Effects of testosterone supplementation on body composition and lower-body muscle function during severe exercise- and diet-induced energy deficit: A proof-of-concept, single centre, randomised, double-blind, controlled trial. EBioMedicine. 2019 Aug; 46:411-422. Pasiakos SM, Berryman CE, Karl JP, Lieberman HR, Orr JS, Margolis LM, Caldwell JA, Young AJ, Montano MA, Evans WJ, Vartanian O, Carmichael OT, Gadde KM, Johannsen NM, Beyl RA, Harris MN, Rood JC. PMID: 31358477; PMCID: PMC6711889.

    View in:

    PubMed

       Mentions:

    23  

       Fields: 

       Translation:

    Humans
  40. Long-Term Weight Loss With Metformin or Lifestyle Intervention in the Diabetes Prevention Program Outcomes Study. Ann Intern Med. 2019 05 21; 170(10):682-690. Apolzan JW, Venditti EM, Edelstein SL, Knowler WC, Dabelea D, Boyko EJ, Pi-Sunyer X, Kalyani RR, Franks PW, Srikanthan P, Gadde KM, Diabetes Prevention Program Research Group. PMID: 31009939; PMCID: PMC6829283.

    View in:

    PubMed

       Mentions:

    69  

       Fields: 

       Translation:

    Humans
  41. Weight Loss Medications in the Treatment of Obesity and Hypertension. Curr Hypertens Rep. 2019 02 12; 21(2):16. Cohen JB, Gadde KM. PMID: 30747357; PMCID: PMC6415530.

    View in:

    PubMed

       Mentions:

    37  

       Fields: 

       Translation:

    Humans
  42. Relationship Between Perceptions of Obesity Causes and Weight Loss Expectations Among Adults. J Nutr Educ Behav. 2019 01; 51(1):86-90. Daigle KM, Gang CH, Kopping MF, Gadde KM. PMID: 30318272; PMCID: PMC6352733.

    View in:

    PubMed

       Mentions:

    6  

       Fields: 

       Translation:

    Humans
  43. Glial acetate metabolism is increased following a 72-h fast in metabolically healthy men and correlates with susceptibility to hypoglycemia. Acta Diabetol. 2018 Oct; 55(10):1029-1036. McDougal DH, Darpolor MM, DuVall MA, Sutton EF, Morrison CD, Gadde KM, Redman LM, Carmichael OT. PMID: 29931424; PMCID: PMC6153507.

    View in:

    PubMed

       Mentions:

    2  

       Fields: 

       Translation:

    HumansCells
  44. Obesity: Pathophysiology and Management. J Am Coll Cardiol. 2018 01 02; 71(1):69-84. Gadde KM, Martin CK, Berthoud HR, Heymsfield SB. PMID: 29301630; PMCID: PMC7958889.

    View in:

    PubMed

       Mentions:

    262  

       Fields: 

       Translation:

    Humans
  45. Pharmacotherapy for Patients with Obesity. Clin Chem. 2018 01; 64(1):118-129. Gadde KM, Apolzan JW, Berthoud HR. PMID: 29054924; PMCID: PMC7379842.

    View in:

    PubMed

       Mentions:

    29  

       Fields: 

       Translation:

    Humans
  46. Physiological and psychological effects of testosterone during severe energy deficit and recovery: A study protocol for a randomized, placebo-controlled trial for Optimizing Performance for Soldiers (OPS). Contemp Clin Trials. 2017 07; 58:47-57. Pasiakos SM, Berryman CE, Karl JP, Lieberman HR, Orr JS, Margolis LM, Caldwell JA, Young AJ, Montano MA, Evans WJ, Vartanian O, Carmichael OT, Gadde KM, Harris M, Rood JC. PMID: 28479217.

    View in:

    PubMed

       Mentions:

    13  

       Fields: 

       Translation:

    Humans
  47. Pharmacotherapy of Obesity: Clinical Trials to Clinical Practice. Curr Diab Rep. 2017 05; 17(5):34. Gadde KM, Pritham Raj Y. PMID: 28378293.

    View in:

    PubMed

       Mentions:

    16  

       Fields: 

       Translation:

    Humans
  48. Efficacy and safety of autoinjected exenatide once-weekly suspension versus sitagliptin or placebo with metformin in patients with type 2 diabetes: The DURATION-NEO-2 randomized clinical study. Diabetes Obes Metab. 2017 07; 19(7):979-988. Gadde KM, Vetter ML, Iqbal N, Hardy E, Öhman P, DURATION-NEO-2 study investigators. PMID: 28205322; PMCID: PMC5485171.

    View in:

    PubMed

       Mentions:

    24  

       Fields: 

       Translation:

    HumansCTClinical Trials
  49. Health-related quality of life in two randomized controlled trials of phentermine/topiramate for obesity: What mediates improvement? Qual Life Res. 2016 May; 25(5):1237-44. Kolotkin RL, Gadde KM, Peterson CA, Crosby RD. PMID: 26446094.

    View in:

    PubMed

       Mentions:

    13  

       Fields: 

       Translation:

    Humans
  50. Weight loss: slow and steady does not win the race. Lancet Diabetes Endocrinol. 2014 Dec; 2(12):927-8. Martin CK, Gadde KM. PMID: 25459210.

    View in:

    PubMed   Mentions:

       Fields: 

       Translation:

    Humans
  51. Obesity medications reduce total body weight by 3-9% compared with placebo, when combined with lifestyle changes. Evid Based Nurs. 2015 Jan; 18(1):29-30. Gadde KM, Yancy WS. PMID: 24842056.

    View in:

    PubMed

       Mentions:

    2  

       Fields: 

       Translation:

    Humans
  52. Weight changes in obese adults 6-months after discontinuation of double-blind zonisamide or placebo treatment. Diabetes Obes Metab. 2014 Aug; 16(8):766-8. Shin JH, Gadde KM, Østbye T, Bray GA. PMID: 25123600; PMCID: PMC4135527.

    View in:

    PubMed

       Mentions:

    5  

       Fields: 

       Translation:

    Humans
  53. Combination phentermine/topiramate for obesity treatment in primary care: a review. Postgrad Med. 2014 Mar; 126(2):110-6. Xiong GL, Gadde KM. PMID: 24685974.

    View in:

    PubMed

       Mentions:

    1  

       Fields: 

       Translation:

    Humans
  54. Current pharmacotherapy for obesity: extrapolation of clinical trials data to practice. Expert Opin Pharmacother. 2014 Apr; 15(6):809-22. Gadde KM. PMID: 24548209.

    View in:

    PubMed

       Mentions:

    11  

       Fields: 

       Translation:

    Humans
  55. Weight loss treatment in obese adults. JAMA. 2013 Dec 18; 310(23):2568. Gadde KM. PMID: 24347000; PMCID: PMC9365294.

    View in:

    PubMed

       Mentions:

    1  

       Fields: 

       Translation:

    Humans
  56. Evaluation of phentermine and topiramate versus phentermine/topiramate extended-release in obese adults. Obesity (Silver Spring). 2013 Nov; 21(11):2163-71. Aronne LJ, Wadden TA, Peterson C, Winslow D, Odeh S, Gadde KM. PMID: 24136928.

    View in:

    PubMed

       Mentions:

    88  

       Fields: 

       Translation:

    HumansCTClinical Trials
  57. Clinical utility of phentermine/topiramate (Qsymia™) combination for the treatment of obesity. Diabetes Metab Syndr Obes. 2013; 6:131-9. Shin JH, Gadde KM. PMID: 23630428; PMCID: PMC3626409.

    View in:

    PubMed

       Mentions:

    24  
  58. Zonisamide for weight reduction in obese adults: a 1-year randomized controlled trial. Arch Intern Med. 2012 Nov 12; 172(20):1557-64. Gadde KM, Kopping MF, Wagner HR, Yonish GM, Allison DB, Bray GA. PMID: 23147455; PMCID: PMC3753218.

    View in:

    PubMed

       Mentions:

    25  

       Fields: 

       Translation:

    Humans
  59. Escitalopram for treatment of night eating syndrome: a 12-week, randomized, placebo-controlled trial. J Clin Psychopharmacol. 2012 Jun; 32(3):341-5. Vander Wal JS, Gang CH, Griffing GT, Gadde KM. PMID: 22544016.

    View in:

    PubMed

       Mentions:

    11  

       Fields: 

       Translation:

    Humans
  60. Two-year sustained weight loss and metabolic benefits with controlled-release phentermine/topiramate in obese and overweight adults (SEQUEL): a randomized, placebo-controlled, phase 3 extension study. Am J Clin Nutr. 2012 Feb; 95(2):297-308. Garvey WT, Ryan DH, Look M, Gadde KM, Allison DB, Peterson CA, Schwiers M, Day WW, Bowden CH. PMID: 22158731; PMCID: PMC3260065.

    View in:

    PubMed

       Mentions:

    255  

       Fields: 

       Translation:

    HumansCTClinical Trials
  61. Phentermine/topiramate for weight reduction and treatment of adverse metabolic consequences in obesity. Drugs Today (Barc). 2011 Dec; 47(12):903-14. Bays HE, Gadde KM. PMID: 22348915.

    View in:

    PubMed

       Mentions:

    9  

       Fields: 

       Translation:

    HumansAnimals
  62. Controlled-release phentermine/topiramate in severely obese adults: a randomized controlled trial (EQUIP). Obesity (Silver Spring). 2012 Feb; 20(2):330-42. Allison DB, Gadde KM, Garvey WT, Peterson CA, Schwiers ML, Najarian T, Tam PY, Troupin B, Day WW. PMID: 22051941; PMCID: PMC3270297.

    View in:

    PubMed

       Mentions:

    233  

       Fields: 

       Translation:

    Humans
  63. Effects of low-dose, controlled-release, phentermine plus topiramate combination on weight and associated comorbidities in overweight and obese adults (CONQUER): a randomised, placebo-controlled, phase 3 trial. Lancet. 2011 Apr 16; 377(9774):1341-52. Gadde KM, Allison DB, Ryan DH, Peterson CA, Troupin B, Schwiers ML, Day WW. PMID: 21481449.

    View in:

    PubMed

       Mentions:

    329  

       Fields: 

       Translation:

    HumansCTClinical Trials
  64. Sexual functioning in obese adults enrolling in a weight loss study. J Sex Marital Ther. 2011; 37(3):224-35. Ostbye T, Kolotkin RL, He H, Overcash F, Brouwer R, Binks M, Syrjala KL, Gadde KM. PMID: 21512941; PMCID: PMC3201733.

    View in:

    PubMed

       Mentions:

    6  

       Fields: 

       Translation:

    Humans
  65. Combination therapy for obesity and metabolic disease. Curr Opin Endocrinol Diabetes Obes. 2009 Oct; 16(5):353-8. Gadde KM, Allison DB. PMID: 19625958.

    View in:

    PubMed

       Mentions:

    12  

       Fields: 

       Translation:

    Humans
  66. Missing data in randomized clinical trials for weight loss: scope of the problem, state of the field, and performance of statistical methods. PLoS One. 2009 Aug 13; 4(8):e6624. Elobeid MA, Padilla MA, McVie T, Thomas O, Brock DW, Musser B, Lu K, Coffey CS, Desmond RA, St-Onge MP, Gadde KM, Heymsfield SB, Allison DB. PMID: 19675667; PMCID: PMC2720539.

    View in:

    PubMed

       Mentions:

    91  

       Fields: 

       Translation:

    Humans
  67. Sample size in obesity trials: patient perspective versus current practice. Med Decis Making. 2010 Jan-Feb; 30(1):68-75. Allison DB, Elobeid MA, Cope MB, Brock DW, Faith MS, Vander Veur S, Berkowitz R, Cutter G, McVie T, Gadde KM, Foster GD. PMID: 19675318; PMCID: PMC2914621.

    View in:

    PubMed

       Mentions:

    5  

       Fields: 

       Translation:

    Humans
  68. The effect of acute tryptophan depletion on emotional distraction and subsequent memory. Soc Cogn Affect Neurosci. 2009 Dec; 4(4):357-68. Wang L, Mullette-Gillman OA, Gadde KM, Kuhn CM, McCarthy G, Huettel SA. PMID: 19628700; PMCID: PMC2799951.

    View in:

    PubMed

       Mentions:

    7  

       Fields: 

       Translation:

    HumansCTClinical Trials
  69. Combination pharmaceutical therapies for obesity. Expert Opin Pharmacother. 2009 Apr; 10(6):921-5. Gadde KM, Allison DB. PMID: 19351275; PMCID: PMC4780673.

    View in:

    PubMed

       Mentions:

    9  

       Fields: 

       Translation:

    Humans
  70. Rational design of a combination medication for the treatment of obesity. Obesity (Silver Spring). 2009 Jan; 17(1):30-9. Greenway FL, Whitehouse MJ, Guttadauria M, Anderson JW, Atkinson RL, Fujioka K, Gadde KM, Gupta AK, O'Neil P, Schumacher D, Smith D, Dunayevich E, Tollefson GD, Weber E, Cowley MA. PMID: 18997675.

    View in:

    PubMed

       Mentions:

    118  

       Fields: 

       Translation:

    HumansAnimals
  71. Zonisamide prevents olanzapine-associated hyperphagia, weight gain, and elevated blood glucose in rats. Neuropsychopharmacology. 2008 Nov; 33(12):2922-33. Wallingford NM, Sinnayah P, Bymaster FP, Gadde KM, Krishnan RK, McKinney AA, Landbloom RP, Tollefson GD, Cowley MA. PMID: 18322467.

    View in:

    PubMed

       Mentions:

    10  

       Fields: 

       Translation:

    AnimalsCells
  72. Childhood socioeconomic status and serotonin transporter gene polymorphism enhance cardiovascular reactivity to mental stress. Psychosom Med. 2008 01; 70(1):32-9. Williams RB, Marchuk DA, Siegler IC, Barefoot JC, Helms MJ, Brummett BH, Surwit RS, Lane JD, Kuhn CM, Gadde KM, Ashley-Koch A, Svenson IK, Suarez EC, Schanberg SM. PMID: 18158371.

    View in:

    PubMed

       Mentions:

    21  

       Fields: 

       Translation:

    Humans
  73. Combination therapy of zonisamide and bupropion for weight reduction in obese women: a preliminary, randomized, open-label study. J Clin Psychiatry. 2007 Aug; 68(8):1226-9. Gadde KM, Yonish GM, Foust MS, Wagner HR. PMID: 17854247.

    View in:

    PubMed

       Mentions:

    21  

       Fields: 

       Translation:

    Humans
  74. A randomized, double-blind, placebo-controlled, multicenter study to assess the efficacy and safety of topiramate controlled release in the treatment of obese type 2 diabetic patients. Diabetes Care. 2007 Jun; 30(6):1480-6. Rosenstock J, Hollander P, Gadde KM, Sun X, Strauss R, Leung A, OBD-202 Study Group. PMID: 17363756.

    View in:

    PubMed

       Mentions:

    20  

       Fields: 

       Translation:

    Humans
  75. Escitalopram treatment of trichotillomania. Int Clin Psychopharmacol. 2007 Jan; 22(1):39-42. Gadde KM, Ryan Wagner H, Connor KM, Foust MS. PMID: 17159458.

    View in:

    PubMed

       Mentions:

    4  

       Fields: 

       Translation:

    HumansCTClinical Trials
  76. Bupropion for weight reduction. Expert Rev Neurother. 2007 Jan; 7(1):17-24. Gadde KM, Xiong GL. PMID: 17187492.

    View in:

    PubMed

       Mentions:

    13  

       Fields: 

       Translation:

    Humans
  77. Cannabinoid-1 receptor antagonist, rimonabant, for management of obesity and related risks. Circulation. 2006 Aug 29; 114(9):974-84. Gadde KM, Allison DB. PMID: 16940206.

    View in:

    PubMed

       Mentions:

    23  

       Fields: 

       Translation:

    Humans
  78. Effect of rimonabant on weight and cardiometabolic risk factors. JAMA. 2006 Aug 09; 296(6):649-50; author reply 650-1. Gadde KM. PMID: 16896103.

    View in:

    PubMed

       Mentions:

    2  

       Fields: 

       Translation:

    Humans
  79. Modafinil for atypical depression: effects of open-label and double-blind discontinuation treatment. J Clin Psychopharmacol. 2006 Aug; 26(4):373-8. Vaishnavi S, Gadde K, Alamy S, Zhang W, Connor K, Davidson JR. PMID: 16855454.

    View in:

    PubMed

       Mentions:

    6  

       Fields: 

       Translation:

    Humans
  80. Bupropion treatment of olanzapine-associated weight gain: an open-label, prospective trial. J Clin Psychopharmacol. 2006 Aug; 26(4):409-13. Gadde KM, Zhang W, Foust MS. PMID: 16855461.

    View in:

    PubMed

       Mentions:

    5  

       Fields: 

       Translation:

    HumansCTClinical Trials
  81. Atomoxetine for weight reduction in obese women: a preliminary randomised controlled trial. Int J Obes (Lond). 2006 Jul; 30(7):1138-42. Gadde KM, Yonish GM, Wagner HR, Foust MS, Allison DB. PMID: 16418753.

    View in:

    PubMed

       Mentions:

    12  

       Fields: 

       Translation:

    Humans
  82. Endocannabinoid receptor antagonists and other emerging pharma-cological strategies for weight reduction. Curr Drug Targets Cardiovasc Haematol Disord. 2005 Dec; 5(6):549-56. Gadde KM. PMID: 16503875.

    View in:

    PubMed

       Mentions:

    1  

       Fields: 

       Translation:

    Humans
  83. Hyperforin plasma level as a marker of treatment adherence in the National Institutes of Health Hypericum Depression Trial. J Clin Psychopharmacol. 2005 Jun; 25(3):243-9. Vitiello B, Shader RI, Parker CB, Ritz L, Harlan W, Greenblatt DJ, Gadde KM, Krishnan KR, Davidson JR. PMID: 15876903.

    View in:

    PubMed

       Mentions:

    7  

       Fields: 

       Translation:

    HumansAnimalsCTClinical Trials
  84. The use of aripiprazole in obsessive-compulsive disorder: preliminary observations in 8 patients. J Clin Psychiatry. 2005 Jan; 66(1):49-51. Connor KM, Payne VM, Gadde KM, Zhang W, Davidson JR. PMID: 15669888.

    View in:

    PubMed

       Mentions:

    33  

       Fields: 

       Translation:

    HumansCTClinical Trials
  85. Fluoxetine, comprehensive cognitive behavioral therapy, and placebo in generalized social phobia. Arch Gen Psychiatry. 2004 Oct; 61(10):1005-13. Davidson JR, Foa EB, Huppert JD, Keefe FJ, Franklin ME, Compton JS, Zhao N, Connor KM, Lynch TR, Gadde KM. PMID: 15466674.

    View in:

    PubMed

       Mentions:

    91  

       Fields: 

       Translation:

    HumansCTClinical Trials
  86. Assessing patient beliefs in a clinical trial of Hypericum perforatum in major depression. Depress Anxiety. 2004; 20(3):114-22. Bann CM, Parker CB, Bradwejn J, Davidson JR, Vitiello B, Gadde KM. PMID: 15549690.

    View in:

    PubMed

       Mentions:

    10  

       Fields: 

       Translation:

    HumansAnimals
  87. Zonisamide for weight loss in obese adults: a randomized controlled trial. JAMA. 2003 Apr 09; 289(14):1820-5. Gadde KM, Franciscy DM, Wagner HR, Krishnan KR. PMID: 12684361.

    View in:

    PubMed

       Mentions:

    49  

       Fields: 

       Translation:

    HumansCTClinical Trials
  88. Bupropion SR vs. placebo for weight loss in obese patients with depressive symptoms. Obes Res. 2002 Oct; 10(10):1049-56. Jain AK, Kaplan RA, Gadde KM, Wadden TA, Allison DB, Brewer ER, Leadbetter RA, Richard N, Haight B, Jamerson BD, Buaron KS, Metz A. PMID: 12376586.

    View in:

    PubMed

       Mentions:

    38  

       Fields: 

       Translation:

    HumansCTClinical Trials
  89. Serotonin-related gene polymorphisms and central nervous system serotonin function. Neuropsychopharmacology. 2003 Mar; 28(3):533-41. Williams RB, Marchuk DA, Gadde KM, Barefoot JC, Grichnik K, Helms MJ, Kuhn CM, Lewis JG, Schanberg SM, Stafford-Smith M, Suarez EC, Clary GL, Svenson IK, Siegler IC. PMID: 12629534.

    View in:

    PubMed

       Mentions:

    91  

       Fields: 

       Translation:

    Humans
  90. Bupropion SR enhances weight loss: a 48-week double-blind, placebo- controlled trial. Obes Res. 2002 Jul; 10(7):633-41. Anderson JW, Greenway FL, Fujioka K, Gadde KM, McKenney J, O'Neil PM. PMID: 12105285.

    View in:

    PubMed

       Mentions:

    69  

       Fields: 

       Translation:

    HumansCTClinical Trials
  91. Effect of Hypericum perforatum (St John's wort) in major depressive disorder: a randomized controlled trial. JAMA. 2002 04 10; 287(14):1807-14. Hypericum Depression Trial Study Group, Davidson JR, Gadde KM, Fairbank JA, Krishnan KRR, Califf RM, Binanay C, Parker CB, Pugh N, Hartwell TD, Vitiello B, Ritz L, Severe J, Cole JO, de Battista C, Doraiswamy PM, Feighner JP, Keck P, Kelsey J, Lin KM, Londborg PD, Nemeroff CB, Schatzberg AF, Sheehan DV, Srivastava RK, Taylor L, Trivedi MH, Weisler RH. PMID: 11939866.

    View in:

    PubMed

       Mentions:

    76  

       Fields: 

       Translation:

    HumansAnimalsCTClinical Trials
  92. Bupropion for weight loss: an investigation of efficacy and tolerability in overweight and obese women. Obes Res. 2001 Sep; 9(9):544-51. Gadde KM, Parker CB, Maner LG, Wagner HR, Logue EJ, Drezner MK, Krishnan KR. PMID: 11557835.

    View in:

    PubMed

       Mentions:

    35  

       Fields: 

       Translation:

    HumansCTClinical Trials
  93. Central nervous system serotonin function and cardiovascular responses to stress. Psychosom Med. 2001 Mar-Apr; 63(2):300-5. Williams RB, Marchuk DA, Gadde KM, Barefoot JC, Grichnik K, Helms MJ, Kuhn CM, Lewis JG, Schanberg SM, Stafford-Smith M, Suarez EC, Clary GL, Svenson IK, Siegler IC. PMID: 11292279.

    View in:

    PubMed

       Mentions:

    34  

       Fields: 

       Translation:

    HumansCellsCTClinical Trials
  94. Psychoneuroendocrinology and brain imaging in depression. Psychiatr Clin North Am. 1998 Jun; 21(2):465-72. Krishnan KR, Gadde KM, Kim YD. PMID: 9670237.

    View in:

    PubMed   Mentions:

       Fields: 

       Translation:

    Humans
  95. Diltiazem effect on carbamazepine levels in manic depression. J Clin Psychopharmacol. 1990 Oct; 10(5):378-9. Gadde K, Calabrese JR. PMID: 2258457.

    View in:

    PubMed

       Mentions:

    1  

       Fields: 

       Translation:

    Humans